ArticleScientific reports2025
Control of biofilm from single and multispecies bacteria associated with food spoilage using metabolite of Streptomyces sp. KP110 and Pseudomonas fluorescens JB 3B.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Food spoilage bacteria are responsible for food spoilage and often fabricate biofilms on various surfaces. Naturally, biofilms are constructed by multiple bacterial species. These biofilms are more difficult to control compared to single species biofilms. Effective multispecies biofilm treatments are necessary in the food industry. This research evaluated antibiofilm activities of Streptomyces sp. KP110 and Pseudomonas fluorescens JB 3B metabolites. Prior to this research, the two antibiofilm crude extracts had shown significant results against various single species biofilms, including Bacillus, Shewanella, Vibrio, etc. The crude extracts also showed quorum-quenching activities, further asserting the antibiofilm potential. This research further characterized these antibiofilm crude extracts against multispecies biofilms, as well as assessing the duration of biofilm formation inhibition. The food spoilage bacteria used in this study are Bacillus cereus, Bacillus subtilis, and Shewanella putrefaciens. Both crude extracts showed antibiofilm activities with better results against Gram-negative bacteria. The metabolites are also considered nontoxic, meaning they are potential candidates for industrial purposes. The dominant active compounds of Streptomyces sp. KP110 are ticlopidine and hexadecanoid acid, while Pseudomonas fluorescens JB 3B are phenol and indole.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.